Michael Shafique
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 18
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 16
- Brain Metastases and Treatment 3
- Co-authors
- Andreas Saltos (12 shared papers)Alberto Chiappori (9 shared papers)Sonam Puri (5 shared papers)Tawee Tanvetyanon (13 shared papers)Jhanelle E. Gray (13 shared papers)Scott Antonia (11 shared papers)Eric B. Haura (11 shared papers)Ben Creelan (12 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Thoracic Oncology (3 papers)Clinical Cancer Research (1 paper)ESMO Open (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Michael Shafique
30 papers receiving 409 citations
Peers
Comparison fields: 5 of 55
- Oncology 287
- Immunology 86
- Pulmonary and Respiratory Medicine 120
- Cancer Research 37
- Molecular Biology 167
Countries citing papers authored by Michael Shafique
This map shows the geographic impact of Michael Shafique's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shafique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shafique more than expected).
Fields of papers citing papers by Michael Shafique
This network shows the impact of papers produced by Michael Shafique. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shafique. The network helps show where Michael Shafique may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Shafique, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 104 | |
| 2 | 2020 | 103 | |
| 3 | 2020 | 35 | |
| 4 | 2019 | 33 | |
| 5 | 2019 | 25 | |
| 6 | 2018 | 17 | |
| 7 | 2018 | 12 | |
| 8 | 2020 | 12 | |
| 9 | 2024 | 10 | |
| 10 | 2013 | 8 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2023 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2020 | 2 |
About Michael Shafique
Michael Shafique is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Immunology, having authored 35 papers that have together received 412 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Brain Metastases and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (287 citations), Immunology (86 citations), Pulmonary and Respiratory Medicine (120 citations), Cancer Research (37 citations) and Molecular Biology (167 citations). Michael Shafique has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Andreas Saltos, Alberto Chiappori, Sonam Puri, Tawee Tanvetyanon, Jhanelle E. Gray, Scott Antonia, Eric B. Haura, Ben Creelan, Dung‐Tsa Chen and Ram Thapa. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Thoracic Oncology, Clinical Cancer Research and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.